| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.071 | 0.07 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.07 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.059 | 0.07 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.07 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.07 |